Drug Database
Back to search

Netherlands· NL-2a1aa26455cb

Ambirix, suspensie voor injectie

A kombinationen (hepatitis a + hepatitis b) product containing hepatitis a virusantigeen, geinactiveerd + hepatitis b oppervlakte antigeen, (rdna, gistafgeleid) "skb biologicals", registered in Netherlands by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC20

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAmbirix, suspensie voor injectieATCJ07BC20REGISTER NO.NL-2a1aa26455cbPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hepatitis a virusantigeen, geinactiveerd + hepatitis b oppervlakte antigeen, (rdna, gistafgeleid) "skb biologicals"Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search kombinationen (hepatitis a + hepatitis b) products by name

Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HEPATITIS A VIRUSANTIGEEN, GEINACTIVEERD + HEPATITIS B OPPERVLAKTE ANTIGEEN, (rDNA, GISTAFGELEID) "SKB BIOLOGICALS"
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Netherlands (NL)
ATC code
J07BC20
ATC class
Kombinationen (Hepatitis A + Hepatitis B)
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/02/224

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BC20

Kombinationen (hepatitis a + hepatitis b), as other registers publish it.

All kombinationen (hepatitis a + hepatitis b) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dcb2b67b-4b22-4a41-bcc8-0e0d7fcab0cf
GET /v1/drugs/dcb2b67b-4b22-4a41-bcc8-0e0d7fcab0cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71491",
  "excipients": [
    "ALUMINIUMFOSFAAT",
    "ALUMINIUMHYDROXIDE 0-WATER",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HEPATITIS A VIRUSANTIGEEN, GEINACTIVEERD",
    "HEPATITIS B OPPERVLAKTE ANTIGEEN, (rDNA, GISTAFGELEID) \"SKB BIOLOGICALS\""
  ],
  "leaflet_url": null,
  "authorised_at": "2002/08/30",
  "procedure_number": "EMEA/H/C/000426",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/02/224",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about kombinationen (hepatitis a + hepatitis b).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console